title: [Local therapy with platelet-derived growth factors for chronic diabetic ulcers in haemodialysis patients].
abstract: BACKGROUND
  The increasing number of diabetic patients who need dialysis treatment is the cause for the growing interest of nephrologists in ulcers of the lower limbs. It has been reported that platelet-derived growth factors, such as PDGF and TGF beta 1, are able to heal skin lesions due to diabetes. Therefore, a platelet gel (PG) has been developed to locally treat foot ulcers with a limited number of applications (3+/-1.7). METHOLOGY AND PATIENTS: The PG is a mix of concentrated platelets and cryoprecipitate activated by batroxobin in the presence of calcium chloride (or gluconate) that must be applied to the wound for three days. The surgeon and the dermatologist should then plan successive treatments because the necrotic tissue needs to be removed. We treated a 62-year-old diabetic man, who has been under treatment with insulin since the age of 36 and has been dialysed for three years. His right lower leg was amputated and he developed a chronic left foot ulcer that resulted in many septic episodes. His ulcer recovered in two months after 8 PG applications.
  
  
  CONCLUSIONS
  Conventional therapy is not successful in 15-20% of diabetic feet. Uraemia and malnutrition may represent important risk factors for foot ulcers in diabetic patients who need advanced technology to stimulate tissue repair. The use of platelet growth factor may ameliorate ulcer healing thus reducing disease-associated morbidity and lowering health care costs.
authors.affiliation: U.O. di Nefrologia e Dialisi, Ospedale S. Martino, Belluno, Italy. giovanni.tarroni@ulss.belluno.it
authors.forename: G
authors.initials: G
authors.lastname: Tarroni
authors.forename: C
authors.initials: C
authors.lastname: Tessarin
authors.forename: L
authors.initials: L
authors.lastname: De Silvestro
authors.forename: D
authors.initials: D
authors.lastname: Casol
authors.forename: M
authors.initials: M
authors.lastname: Giozzet
authors.forename: G
authors.initials: G
authors.lastname: Caloprisco
authors.forename: E
authors.initials: E
authors.lastname: De Paoli Vitali
mesh_terms: D000287:Administration, Topical; D002908:Chronic Disease; D017719:Diabetic Foot / Q000188:drug therapy*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010982:Platelet-Derived Growth Factor / Q000008:administration & dosage*; D006435:Renal Dialysis
chemical_list: D010982:Platelet-Derived Growth Factor